Hindelang, M. ; Kirsch, F. ; Leidl, R.
Effectiveness of non-pharmacological COPD management on health-related quality of life-a systematic review.
Expert Rev. Pharmacoecon. Outcomes Res. 20, 79-91 (2020)
Szentes, B.L. ; Schwarzkopf, L. ; Kirsch, F. ; Schramm, A.* ; Leidl, R.
Measuring quality of life in COPD patients: Comparing disease-specific supplements to the EQ-5D-5L.
Expert Rev. Pharmacoecon. Outcomes Res. 20, 523-529 (2019)
Kirsch, F.
A systematic review of quality and cost-effectiveness derived from Markov models evaluating smoking cessation interventions in patients with chronic obstructive pulmonary disease.
Expert Rev. Pharmacoecon. Outcomes Res. 15, 301-316 (2015)
Kirsch, F.
A systematic review of Markov models evaluating multicomponent disease management programs in diabetes.
Expert Rev. Pharmacoecon. Outcomes Res. 15, 961-984 (2015)
Müller, D.* ; Gerber-Grote, A.* ; Stollenwerk, B. ; Stock, S.* ; Auweiler, P.* ; Frey, S.* ; Adarkwah, C.C.* ; de Kinderen, R.* ; Hellmich, M.*
Reporting health care decision models: A prospective reliability study of a multidimensional evaluation framework.
Expert Rev. Pharmacoecon. Outcomes Res. 16, 619-627 (2015)
Becker, C.
Cost-of-illness studies of atrial fibrillation: Methodological considerations.
Expert Rev. Pharmacoecon. Outcomes Res. 14, 661-684 (2014)
John, J. ; Teuner, C.M.
Combating pediatric obesity in Germany: The role of economic findings in informing policy.
Expert Rev. Pharmacoecon. Outcomes Res. 12, 733-743 (2012)
Becker, C. ; Langer, A. ; Leidl, R.
The quality of three decision-analytic diabetes models: A systematic health economic assessment.
Expert Rev. Pharmacoecon. Outcomes Res. 11, 751-761 (2011)